Tribosovo Ivosidenib Tablets act as a drug that is used to treat a specific type of acute myeloid leukaemia caused by a genetic mutation. Ivosidenib inhibits an enzyme that is mutated in certain types of AML. Ivosidenib, by inhibiting this enzyme, can help to slow or stop the growth and spread of cancer cells. Tribosovo Ivosidenib Tablets are typically taken once daily, with or without food, as directed by a healthcare provider. The dosage and duration of treatment are determined by the patient's specific needs. Patients should also inform their healthcare provider if they are taking any other medications.